Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myelodysplastic Syndromes 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Recurrence 1Neoplasms 1Myocarditis 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Hodgkin Disease 1Hematologic Neoplasms 1Graft vs Host Disease 1

Interventions

Specimen Handling 2Biopsy 2ruxolitinib 1onvansertib 1axatilimab 1Watchful Waiting 1Positron-Emission Tomography 1Hyperbaric Oxygenation 1High-Energy Shock Waves 1Azacitidine 1Abatacept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative × Abatacept × Clear all
NCT07238712 2025-11-20

APTBCy

St. Petersburg State Pavlov Medical University

Phase 2 Recruiting
60 enrolled
MyeloidOther hematologic neoplasm

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡